External Funding Opportunities
The following links are provided as informational opportunities towards funding research in the area of the digestive diseases:
AGA STUDENT RESEARCH FELLOWSHIP AWARDS
PURPOSE
Awards are offered to support high school, college, medical, or graduate students performing digestive disease or nutrition research for a minimum of 10 weeks. Details regarding this funding opportunity can be found at: http://www.fdhn.org/html/awards/elect_app.html Click here for a link to the pdf application/description.
EVOLUTIONARY MECHANISMS IN INFECTIOUS DISEASE: PA-02-113
PURPOSE
The goal of the announcement is to encourage development of a predictive science of infectious disease by applying the perspectives, theories, and methods from relevant scientific disciplines to important issues of disease emergence, prevention, and the consequences of treatment. Research projects involving interdisciplinary collaborations are an explicit goal of this announcement. Approaches might include, but are not limited to, evolutionary biology, microbiology, population dynamics, chemistry, biochemistry, and computational biology. The focus is limited to discovery of fundamental biological principles rather than to detailed knowledge or treatement of specific diseases. http://grants2.nih.gov/grants/guide/pa-files/PA-02-113.html
LIVER AND PANCREATIC DISEASE IN HIV INFECTION PA NUMBER: PA-01-117
PURPOSE
The National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID) invite clinical and basic research applications that focus on the pathogenesis and therapeutics of the liver and pancreatic disease associated with coinfections that occur in patients with HIV infection or the metabolic complications associated with treatment of HIV infection. The coinfections targeted by this Program Announcement (PA) specifically include hepatitis B and hepatitis C, which are frequent causes of end-stage liver disease, a leading cause of death in HIV infected patients. Metabolic complications, involving the liver and pancreas, associated with the treatment of HIV infection include: hepatic drug toxicity, hepatic lipid metabolism, nonalcoholic steatohepatitis (NASH) and pancreatitis, which are all important causes of morbidity in patients with HIV infection. The proposed studies should advance our understanding of the pathogenesis of liver and pancreatic disease in patients with HIV and/or metabolic complications of therapy. These advances should lead to enhanced medical management of individuals infected with HIV. Click on the following link to obtain further information: http://grants.nih.gov/grants/guide/pa-files/PA-01-117.html
PROTEOMICS: DIABETES, OBESITY, AND ENDOCRINE, DIGESTIVE, KIDNEY, UROLOGIC, AND HEMATOLOGIC DISEASES
PURPOSE
This Program Announcement (PA) encourages projects that advance research to identify and quantitate protein expression patterns, post-translational modification of proteins, and protein-protein interactions on cells, tissues, organ systems to diabetes, obesity, endocrine and metabolic diseases, nutritional function and diseases of the alimentary tract, exocrine pancreas, liver, kidney, bladder and prostate and normal biological processes related to the function of these systems. The development and improvement of innovative proteomic technologies is also encouraged through their application to relevant biological questions related to the pathophysiology of endocrine glands, gastrointestinal tract, liver and kidney, bladder and prostate. Click on the following link to obtain further information: http://www.nih.gov/grants/guide/pa-files/PA-04-081.html
DEVELOPMENT OF ASSAYS FOR HIGH THROUGHPUT DRUG SCREENING
PURPOSE
The purpose of this PA is to encourage the use of high throughput small molecule screening for use in both research and drug discovery programs by funding the development of innovative assays that may be adapted for automated screening. The assays would aim to identify new tools for basic research and promising new avenues for therapeutics development, especially in areas related to the missions of NIDDK, NCI and NIAID. Click on the following link to obtain further information: http://www.nih.gov/grants/guide/pa-files/PA-04-068.html
SMALL CLINICAL GRANTS IN DIGESTIVE DISEASES, NUTRITION AND OBESITY
PURPOSE
This PAR supersedes PAR-01-056 published in 2001. The goal of this initiative is to encourage innovative clinical and epidemiological research into new therapies or means of prevention of digestive and liver diseases, nutritional disorders and obesity. The Small Clinical Research Grants Program is designed to support short-term clinical studies and help stimulate the translation of promising and potentially relevant new developments from the laboratory into the clinical setting. This PAR specifically encourages the submission of applications for pilot studies relating to gastrointestinal, pancreatic and liver diseases and nutritional disorders including obesity. They should focus on research that is particularly innovative and/or potentially of high impact. High impact research involves feasibility studies in which the technological, methodological, or theoretical approach to a problem lacks an historical precedent or sufficient preliminary data, but whose successful outcome would have a major effect on a scientific area. Click on the following link to obtain further information: http://www.nih.gov/grants/guide/pa-files/PAR-04-082.html
ANCILLARY STUDIES TO MAJOR ONGOING NIDDK CLINICAL RESEARCH STUDIES
PURPOSE
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites investigator-initiated research project applications for ancillary studies to ongoing large-scale clinical trials, epidemiological studies and disease databases supported by the Institute. These studies are focused on a wide range of diseases and conditions including diabetes, obesity, acute and chronic liver disease, chronic kidney disease, benign prostatic hyperplasia, among others. The goal of these ancillary study proposals must complement but not overlap or interfere with the primary and secondary objectives of the parent study. Each applicant must abide by the procedures for conducting ancillary studies established by the parent study group. Click on the following link to obtain further information: http://www.nih.gov/grants/guide/pa-files/PAR-04-078.html
Updated: 12/30/04